Exercise and Cardiovascular Response
Coronary Artery Disease IV: Preventive Measures
Psychoneuroimmunology: Cardiovascular Disease
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease I: Introduction
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Sep 4, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Larisa G Tereshchenko1, Adam Bishop2, Nora Fisher-Campbell2
1Knight Cardiovascular Institute and Division of Pulmonary and Critical Care Medicine, School of Medicine, Oregon Health & Science University, Portland, Oregon; Department of Quantitative Health Sciences, Cleveland Clinic Lerner Research Institute, Cleveland, Ohio.
SARS-CoV-2 infection, even asymptomatic, increases cardiovascular risks and mortality. This study found COVID-19 survivors face higher late CV events and reduced survival time post-infection.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: